Investing Profile

Tuyen Ong

InvestorVCCEO
CEO partner at Flagship Pioneering
flagshippioneering.com/people...Cambridge, Massachusetts
Photo of Tuyen Ong, Partner at Flagship Pioneering

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Hotmail Network
5844 CONNECTIONS
Flagship Pioneering Network
100 CONNECTIONS
Pfizer Network
86 CONNECTIONS
Biogen Network
24 CONNECTIONS
cb
$500K - $15.0M
$7.0M
2
CompanyStageDateRound SizeTotal Raised
Ring Therapeutics
Series CMar 2023$87M
Series BJul 2021$120M
$200M
Co-investors: Avak Kahvejian (Flagship Pioneering)
EVP, Chief Development Officer HotmailPresent
VP, Clinical Development and Operations Bausch + LombPresent
Global Clinical Lead PfizerPresent
Chief Medical Officer PTC Therapeutics, Inc.Present
Board of Advisors Nevakar PharmaceuticalsPresent
EVP, Chief Development Officer Nightstar TherapeuticsPresent
SVP, Head of Ophthalmology Franchise BiogenPresent
Board of Directors Disc MedicinePresent
Member Board of Directors Rectify PharmaPresent
Chief Executive Officer Ring TherapeuticsPresent
CEO partner Flagship PioneeringPresent
CEO - Cofounder Pharmas MarketPresent
Sign in with Google →
Sign in with Google →